[1]王俊瑛,周 岚,李 燕,等.单用氨基葡萄糖治疗骨关节炎有效性和安全性的Meta分析[J].医学信息,2023,36(03):119-124.[doi:10.3969/j.issn.1006-1959.2023.03.024]
　WANG Jun-ying,ZHOU Lan,LI Yan,et al.Meta-analysis of the Efficacy and Safety of Glucosamine Alone in the Treatment of Osteoarthritis[J].Journal of Medical Information,2023,36(03):119-124.[doi:10.3969/j.issn.1006-1959.2023.03.024]
点击复制

单用氨基葡萄糖治疗骨关节炎有效性和安全性的Meta分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年03期
页码:
119-124
栏目:
论著
出版日期:
2023-02-01

文章信息/Info

Title:
Meta-analysis of the Efficacy and Safety of Glucosamine Alone in the Treatment of Osteoarthritis
文章编号:
1006-1959（2023）03-0119-06
作者:
王俊瑛; 周 岚; 李 燕; 等
（1.昆明医科大学图书馆，云南 昆明 650500；2.昆明医科大学第三附属医院临床营养科，云南 昆明 650100；3.昆明医科大学公共卫生学院，云南 昆明 650500）
Author(s):
WANG Jun-ying; ZHOU Lan; LI Yan; et al.
(1.Library of Kunming Medical University,Kunming 650500,Yunnan,China; 2.Department of Clinical Nutrition,the Third Affiliated Hospital of Kunming Medical University,Kunming 650100,Yunnan,China;3.School of Public Health,Kunming Medical University,Kunming 650500,Yunnan,China)
关键词:
氨基葡萄糖; 骨关节炎; VAS疼痛评分; WOMAC评分; 随机对照试验
Keywords:
Glucosamine; Osteoarthritis; VAS pain score; WOMAC score; Randomized controlled trials
分类号:
R195.1；R684
DOI:
10.3969/j.issn.1006-1959.2023.03.024
文献标志码:
A
摘要:
目的 系统评价单独使用氨基葡萄糖治疗骨关节炎的有效性和安全性，为临床上使用氨基葡萄糖治疗骨关节炎提供循证参考。方法 检索CNKI、VIP、CBM、WanFang Data、PubMed、EMbase和The Cochrane Library等中外文数据库，收集建库以来至2021年6月30日公开发表的单独使用氨基葡萄糖治疗骨关节炎的随机对照试验（RCTs）文献。采用VAS疼痛评分、WOMAC评分以及药物不良反应发生率等指标系统评价单独使用氨基葡萄糖治疗骨关节炎的有效性及安全性。采用RevMan5.4软件进行Meta分析。结果 共有11篇RCTs文献纳入Meta分析，包括1962例患者，其中试验组985例，对照组977例。Meta分析结果显示，以VAS评分改变量进行Meta分析时，试验组与对照组比较差异无统计学意义[MD=-0.13，95%CI（-0.49,0.23）]，P=0.47]；以WOMAC疼痛评分改变量进行Meta分析，试验组与对照组比较差异无统计学意义[MD=-1.13，95%CI（-3.18,0.92），P=0.28]；以WOMAC身体功能评分改变量进行Meta分析，试验组与对照组比较差异无统计学意义[MD=-1.18，95%CI（-3.05,0.69），P=0.21]；以WOMAC总评分改变量进行Meta分析，试验组与对照组比较差异无统计学意义[MD=-1.39，95%CI（-5.84,3.06），P=0.54]；以不良事件发生情况进行Meta分析，试验组与对照组比较差异无统计学意义[OR=1.10，95%CI（0.56,2.15），P=0.78]。结论 单用氨基葡萄糖（≤1500 mg/d）未减轻骨关节炎疼痛和改善骨关节功能，但其安全性较好。提示需要更多高质量的研究明确其疗效。
Abstract:
Objective To systematically evaluate the efficacy and safety of glucosamine alone in the treatment of osteoarthritis, and to provide evidence-based reference for the clinical use of glucosamine in the treatment of osteoarthritis.Methods CNKI, VIP, CBM, WanFang Data, PubMed, EMbase and The Cochrane Library were searched to collect the randomized controlled trials (RCTs) of glucosamine alone in the treatment of osteoarthritis published from the establishment of the database to June 30, 2021. The efficacy and safety of glucosamine alone in the treatment of osteoarthritis were systematically evaluated by VAS pain score, WOMAC score and incidence of adverse drug reactions. Meta-analysis was performed using RevMan 5.4 software.Results A total of 11 RCTs studies involving 1962 patients were included (985 patients in the experimental group and 997 patients in the control group). The meta-analyses were performed by VAS score changes, there was no statistically significant difference between the experimental group and the control group[MD=-0.13,95%CI(-0.49,0.23)]，P=0.47]; the meta-analysis was performed by the amount of WOMAC pain score change, and there was no statistically significant difference between the experimental group and the control group[MD=-1.13,95%CI(-3.18,0.92),P=0.28]; the meta-analysis was performed by the amount of change in WOMAC body function score, and the difference between the experimental group and the control group was not statistically significant[MD=-1.18,95%CI(-3.05,0.69),P=0.21]；The meta-analysis was performed by the WOMAC total score change, and the difference between the experimental group and the control group was not statistically significant[MD=-1.39,95%CI(-5.84,3.06)，P=0.54];the meta-analysis was performed by the adverse events, there was no statistically significant difference between the experimental group and the control group[OR=1.10,95%CI(0.56,2.15)，P=0.78].Conclusion Glucosamine alone (≤1500 mg/d) does not reduce osteoarthritis pain and improve bone and joint function, but it is safe. It is suggested that more high-quality studies are needed to clarify its efficacy.

参考文献/References:

[1]Ma Q,Gao X.Categories and biomanufacturing methods of glucosamine[J].Appl Microbiol Biotechnol,2019,103(19):7883-7889.[2]苏剑.氨基葡萄糖治疗骨关节炎的专家共识[J].江苏卫生保健,2018(4):52.[3]Roman-Blas JA,Casta?觡eda S,Sánchez-Pernaute O,et al.Combined Treatment With Chondroitin Sulfate and Glucosamine Sulfate Shows No Superiority Over Placebo for Reduction of Joint Pain and Functional Impairment in Patients With Knee Osteoarthritis: A Six-Month Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial[J].Arthritis Rheumatol,2017,69(1):77-85.[4]Lubis AMT,Siagian C,Wonggokusuma E,et al.Comparison of Glucosamine-Chondroitin Sulfate with and without Methylsulfonylmethane in GradeⅠ-ⅡKnee Osteoarthritis: A Double Blind Randomized Controlled Trial[J].Acta Med Indones,2017,49(2):105-111.[5]Fransen M,Agaliotis M,Nairn L,et al.Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomized placebo-controlled clinical trial evaluating single and combination regimens[J].Annals of the Rheumatic Diseases,2015,74(5):851-858.[6]许颖.硫酸氨基葡萄糖治疗膝骨关节炎疗效和安全性[J].农垦医学,2021,43(2):126-128,147.[7]孙永红,罗东方,詹志军.复方盐酸氨基葡萄糖胶囊与片剂治疗骨关节炎疗效及安全性的对比研究[J].中国医院用药评价与分析,2016,16(11):1524-1526.[8]Lomonte ABV,Mendon?觭a JA,de Castro Brand?觔o G,et al.Multicenter, randomized, double-blind clinical trial to evaluate efficacy and safety of combined glucosamine sulfate and chondroitin sulfate capsules for treating knee osteoarthritis[J].Adv Rheumatol,2018,58(1):41.[9]陈汉其.盐酸氨基葡萄糖片治疗膝骨关节炎的临床研究[J].名医,2021(18):23-24.[10]Eraslan A,Ulkar B.Glucosamine supplementation after anterior cruciate ligament reconstruction in athletes: a randomized placebo-controlled trial[J].Res Sports Med,2015,23(1):14-26.[11]Kwoh CK,Roemer FW,Hannon MJ,et al.Effect of oral glucosamine on joint structure in individuals with chronic knee pain: a randomized, placebo-controlled clinical trial[J].Arthritis ＆ Rheumatology,2014,66(4):930-939.[12]Madhu K,Chanda K,Saji MJ.Safety and efficacy of Curcuma longa extract in the treatment of painful knee osteoarthritis: a randomized placebo-controlled trial[J].Inflammopharmacol,2013,21(2):129-136.[13]Gokan N,Suzuki N,Shiizuka K,et al.The effect of the dietary supplement containing with both glucosamine and chondroitin sulfate on knee joint pain[J].J New Rem Clin,2011,60(7):186-192.[14]Cahlin BJ,Dahlstr?觟m L.No effect of glucosamine sulfate on osteoarthritis in the temporomandibular joints—a randomized, controlled,short-term study[J].Oral Surg Oral Med Oral Pathol Oral Radiol Endod,2011,112(6):760-766.[15]Chopra A,Saluja M,Tillu G,et al.A Randomized Controlled Exploratory Evaluation of Standardized Ayurvedic Formulations in Symptomatic Osteoarthritis Knees: A Government of India NMITLI Project[J]. Evid Based Complement Alternat Med,2011:724291.[16]Chopra A,Saluja M,Tillu G,et al.Clinical efficacy and safety of glucosamine，chondroitin sulphate,their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT[J].Annals of the Rheumatic Diseases,2010,69(8):1459-1464.[17]Cibere J,Kopec JA,Thorne A,et al.Randomized,double blind, placebo-controlled glucosamine discontinuation trial in knee osteoarthritis[J].Arthritis & Rheumatism,2004,51(5):738-745.[18]Clegg DO,Reda DJ,Harris CL,et al.Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis[J].New England Journal of Medicine,2006,354(8):795-808.[19]Herrero-Beaumont G,Ivorra JA,Del Carmen Trabado M,et al.Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator[J].Arthritis and Rheumatism,2007,56(2):555-567.[20]Zhu X,Sang L,Wu D,et al.Effectiveness and safety of glucosamine and chondroitinfor the treatment of osteoarthritis: a meta-analysis of randomized controlled trials a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator[J].J Orthop Surg Res,2018,13(1):170.[21]Ogata T,Ideno Y,Akai M,et al.Effects of glucosamine inpatients with osteoarthritis of the knee: a systematic review and meta-analysis[J].Clin Rheumatol,2018,37(9):2479-2487.[22]陈兴剑,宋赟.仙灵骨葆胶囊联合盐酸氨基葡萄糖治疗膝关节骨性关节炎临床研究[J].实用中医药杂志,2022,38(6):1013-1014.[23]付玉.独活寄生合剂联合氨基葡萄糖治疗肝肾亏虚型膝骨关节炎的临床观察[D].长沙:湖南中医药大学,2020.[24]刘勇.盐酸氨基葡萄糖胶囊联合透明质酸钠治疗膝关节骨性关节炎的临床疗效[J].临床合理用药杂志,2019,12(21):67-68.

相似文献/References:

[1]于 洋.滑膜细胞与骨关节炎疾病的相关性研究[J].医学信息,2022,35(20):170.[doi:10.3969/j.issn.1006-1959.2022.20.047]
　YU Yang.Study on the Correlation Between Synovial Cells and Osteoarthritis Disease[J].Journal of Medical Information,2022,35(03):170.[doi:10.3969/j.issn.1006-1959.2022.20.047]
[2]吴常杰,潘 莉,谭 捷,等.膝骨关节炎患者生活质量主要维度的相关因素分析[J].医学信息,2020,33(18):59.[doi:10.3969/j.issn.1006-1959.2020.18.018]
　WU Chang-jie,PAN Li,TAN Jie,et al.Analysis of Related Factors in Main Dimensions of Quality of Life of Patients with Knee Osteoarthritis[J].Journal of Medical Information,2020,33(03):59.[doi:10.3969/j.issn.1006-1959.2020.18.018]
[3]刘泽朋,李春洪,姚志杰.单髁置换术联合关节镜治疗膝前内侧骨关节炎伴外侧半月板退变患者的疗效[J].医学信息,2020,33(22):110.[doi:10.3969/j.issn.1006-1959.2020.22.031]
　LIU Ze-peng,LI Chun-hong,YAO Zhi-jie.Efficacy of Unicondylar Knee Arthroplasty Combined with Arthroscopy in the Treatment of Knee Anteromedial Osteoarthritis with Lateral Meniscus Degeneration[J].Journal of Medical Information,2020,33(03):110.[doi:10.3969/j.issn.1006-1959.2020.22.031]
[4]潘盛强,李 宁.TLRs信号通路介导下相关因子对骨关节炎的干预机制[J].医学信息,2023,36(02):167.[doi:10.3969/j.issn.1006-1959.2023.02.037]
　PAN Sheng-qiang,LI Ning.Intervention Progress of Related Factors in Osteoarthritis Mediated by TLRs Signal Pathway[J].Journal of Medical Information,2023,36(03):167.[doi:10.3969/j.issn.1006-1959.2023.02.037]
[5]李 波.IL-17A及IL-17F基因多态性与骨关节炎发病风险关系的Meta分析[J].医学信息,2021,34(20):85.[doi:10.3969/j.issn.1006-1959.2021.20.021]
　LI Bo.Meta-analysis of the Relationship Between IL-17A and IL-17F GenePolymorphisms and the Risk of Osteoarthritis[J].Journal of Medical Information,2021,34(03):85.[doi:10.3969/j.issn.1006-1959.2021.20.021]

更新日期/Last Update: 1900-01-01